Comparison of Compartmental and Non-Compartmental Analysis to Detect Biopharmaceutical Similarity of Intravenous Nanomaterial-Based Rifabutin Formulations
Pharmacometric analysis is often used to quantify the differences and similarities between formulation prototypes. In the regulatory framework, it plays a significant role in the evaluation of bioequivalence. While non-compartmental analysis provides an unbiased data evaluation, mechanistic compartm...
Main Authors: | Nadezhda Osipova, Andrey Budko, Olga Maksimenko, Elena Shipulo, Ludmila Vanchugova, Wenqian Chen, Svetlana Gelperina, Matthias G. Wacker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1258 |
Similar Items
-
Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01) -
Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin
by: A. P. Kaplun, et al.
Published: (2010-04-01) -
Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease
by: Thomas Dick, et al.
Published: (2020-02-01) -
Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure
by: Jihee Sung, et al.
Published: (2017-02-01) -
A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
by: Miranda Monk, et al.
Published: (2022-06-01)